All Insights
Exploring the science, practice, and business of medicine.
Search and Filter Insights
Showing 10 out of 63 Insights
-
Active Filters
-
Can natural experiments help shape health care?
Anupam B. Jena, MD, PhD, the Ruth L. Newhouse Associate Professor of Health Care Policy at Harvard Medical School and a faculty research fellow at the National Bureau of Economic Research, discusses using creative thinking to devise natural experiments that can help guide health care and spending.
-
RWD: Responding to Regulatory and Drug Development Challenges
Rebecca Miksad, MD, MPH, a senior medical director of Flatiron Health, medical oncologist and health outcomes researcher, discusses how real-world data address regulatory and drug development challenges.
-
Modeling COVID-19 as US restrictions lift, state by state
Jagpreet Chhatwal, PhD, an assistant professor at Harvard Medical School and decision scientist at MGH Institute for Technology Assessment, discusses the challenges of building an interactive COVID-19 modeling tool and its real-world impact.
-
Leveraging Genetic Insights Throughout the Drug Discovery Pipeline
Robert M. Plenge, MD, PhD, senior vice president in research and early development and head of the immunology, cardiovascular, fibrosis, and global health research team at Bristol Myers Squibb, discusses leveraging genetic insights in drug discovery.
-
New Venture to Translate Promising Science into Novel Treatments for Autism
Lauren Orefice, PhD, assistant professor in the Department of Genetics at the Blavatnik Institute at Harvard Medical School and the Department of Molecular Biology at Massachusetts General Hospital, discusses steps toward translating promising science into novel treatments for autism.
-
Going Inside the Health Care Ecosystem
Health Care Business Imperative: Functioning at an Increasingly Complicated Intersection with the Patient at the Center of Care
-
Fewer Hospital Readmissions? Challenging Pay-for-Performance
J. Michael McWilliams, MD, PhD, the Warren Alpert Foundation Professor of Health Care Policy at the Blavatnik Institute at Harvard Medical School and an internist at Brigham and Women’s Hospital, discusses hospital readmissions and pay-for-performance measures.
-
Emerging Solutions for Administrative Burden and Provider Burnout
David Y. Ting, chief medical information officer of the Massachusetts General Physicians Organization in Boston and co-director of the MGH Center for Innovation in Digital HealthCare, discusses technologies aimed at easing administrative burden and provider burnout.
-
Advancing Genomic Editing and Organoids
Genomic scientist George Church, PhD, professor of Genetics at Harvard Medical School, discusses approaches to genome editing and applications for organoids in drug discovery and development.
-
Tracing the Arc of Precision Therapies for Kidney Disease
Physician-scientist Anna Greka, MD, PhD, associate professor at Harvard Medical School, founding director of Kidney NExT at Brigham and Women’s Hospital and director of the Broad Institute Kidney Disease Initiative, discusses groundbreaking work on a rare kidney disease, prospects for new therapeutics and collaborating on drug development.
